Literature DB >> 12038812

Evidence of oxidative imbalance in long-term liver transplant patients.

F Trevisani1, P Caraceni, M Simoncini, M Micati, M Domenicali, F Dazzani, A Zambruni, C Stefanelli, G Grazi, B Nardo, C Guarnieri, M Bernardi.   

Abstract

BACKGROUND: Oxidative stress in patients undergoing liver transplantation results both from the pre-existing cirrhosis and ischaemia-reperfusion injury related to surgery. Previous studies have provided information limited to the immediate post-operative period. It remains to be established whether this oxidative imbalance is reversed in a longer time. AIM, METHODS AND PATIENTS: This study aimed to compare plasma concentrations of thiobarbituric acid-reactant substances and alpha-tocopherol in 20 cirrhotic patients before liver transplantation and 22 patients in whom transplant had been carried out at least 6 months previously. Thirty healthy age and sex-matched volunteers served as controls (cross-sectional study). Five patients were evaluated before and after liver transplantation (longitudinal study). RESULTS AND
CONCLUSIONS: Pre-transplant patients showed greater thiobarbituric acid-reactant substances and lower alpha-tocopherol levels than controls. Transplanted patients presented lower thiobarbituric acid-reactant substances and greater alpha-tocopherol levels than cirrhotic patients without reaching, however, the levels observed in controls. No correlations were found between oxidative parameters and liver tests. Hypertransaminasaemia, liver disease recurrence, and rejection episodes did not significantly influence the oxidative parameters. In the longitudinal study, transplantation induced a significant decrease in plasma thiobarbituric acid-reactant substances and a rise in alpha-tocopherol. Although a long-term improvement in the oxidative injury observed in cirrhotic patients occurs after liver transplantation, mild oxidative stress persists even in successfully transplanted patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038812     DOI: 10.1016/s1590-8658(02)80148-7

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

1.  Oxidative stress profile in the post-operative patients with biliary atresia.

Authors:  Takahiro Asakawa; Yoshiaki Tanaka; Kimio Asagiri; Hidefumi Kobayashi; Ken Tanikawa; Minoru Yagi
Journal:  Pediatr Surg Int       Date:  2008-11-14       Impact factor: 1.827

2.  Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

Authors:  Sheng-Lan Wang; Xin-Yan Zhu; Dong-Wei Zhang; Zhao-Jie Zhang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Ischemic preconditioning-like effect of polyunsaturated fatty acid-rich diet on hepatic ischemia/reperfusion injury.

Authors:  Ana Maria Mendonça Coelho; Marcel Cerqueira Cesar Machado; Hilton Kenji Takahashi; Sandra N Sampietre; José Tadeu Stefano; Andre Zonetti A Leite; Rui Curi; Luiz A Carneiro D'Albuquerque
Journal:  J Gastrointest Surg       Date:  2011-08-09       Impact factor: 3.452

4.  Nonalcoholic fatty liver disease following liver transplantation.

Authors:  Sanjaya Kumar Satapathy; Satheesh Nair; Jason M Vanatta
Journal:  Hepatol Int       Date:  2013-04-26       Impact factor: 6.047

5.  Cardiac autonomic modulation in children with severe liver disease, before and after liver transplantation.

Authors:  Renata Salatini; Joice Amaral; Rodrigo Daminello Raimundo; Fernando Rocha; Luiz Carlos de Abreu; Mauro Morais; Uenis Tannuri; Ana Cristina Tannuri
Journal:  Transl Pediatr       Date:  2022-04

6.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

7.  Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Leonardo Lorente; Sergio T Rodriguez; Pablo Sanz; Pedro Abreu-González; Dácil Díaz; Antonia M Moreno; Elisa Borja; María M Martín; Alejandro Jiménez; Manuel A Barrera
Journal:  Int J Mol Sci       Date:  2016-04-05       Impact factor: 5.923

8.  Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival.

Authors:  Leonardo Lorente; Sergio T Rodriguez; Pablo Sanz; Antonia Pérez-Cejas; Pedro Abreu-González; Javier Padilla; Dácil Díaz; Antonio González; María M Martín; Alejandro Jiménez; Purificación Cerro; Manuel A Barrera
Journal:  J Int Med Res       Date:  2018-06-18       Impact factor: 1.671

Review 9.  New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  Leonardo Lorente
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.